GOSSAMER BIO, INC. (GOSS) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
16/53
1.5 / 5 stars
All 53 Win/Lose results and 67 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseGOSS / S&P -49.85% / 15.20% |
WinGOSS / S&P 32.43% / 15.00% |
LoseGOSS / S&P 12.90% / 50.40% |
| 2026-Q11/3 |
LoseGOSS / S&P -89.39% / -4.33% |
LoseGOSS / S&P -55.42% / 11.30% |
WinGOSS / S&P 243.48% / 27.70% |
| 2025-Q42/3 |
WinGOSS / S&P 17.87% / 2.65% |
LoseGOSS / S&P -57.74% / 9.00% |
WinGOSS / S&P 188.46% / 13.40% |
| 2025-Q32/3 |
WinGOSS / S&P 113.82% / 8.12% |
LoseGOSS / S&P -58.17% / 4.61% |
WinGOSS / S&P 165.38% / 13.45% |
| 2025-Q22/3 |
WinGOSS / S&P 11.82% / 10.94% |
LoseGOSS / S&P -58.02% / 4.83% |
WinGOSS / S&P 87.88% / 10.63% |
| 2025-Q11/2 |
WinGOSS / S&P 21.55% / -4.27% |
No dataGOSS / S&P / 4.98% |
LoseGOSS / S&P -77.00% / 10.57% |
| 2024-Q40/2 |
LoseGOSS / S&P -8.22% / 2.41% |
No dataGOSS / S&P / 5.25% |
LoseGOSS / S&P -80.45% / 6.15% |
| 2024-Q31/2 |
WinGOSS / S&P 9.43% / 5.89% |
No dataGOSS / S&P / 5.89% |
LoseGOSS / S&P -85.14% / 6.11% |
| 2024-Q20/2 |
LoseGOSS / S&P -23.64% / 4.28% |
No dataGOSS / S&P / 5.38% |
LoseGOSS / S&P -84.93% / 5.12% |
| 2024-Q11/2 |
WinGOSS / S&P 29.24% / 10.56% |
No dataGOSS / S&P / 5.71% |
LoseGOSS / S&P -59.68% / 5.59% |
| 2023-Q40/2 |
LoseGOSS / S&P 9.60% / 11.69% |
No dataGOSS / S&P / 6.81% |
LoseGOSS / S&P -51.10% / 7.78% |
| 2023-Q30/2 |
LoseGOSS / S&P -30.58% / -3.27% |
No dataGOSS / S&P / 7.52% |
LoseGOSS / S&P -39.66% / -5.03% |
| 2023-Q20/2 |
LoseGOSS / S&P -4.76% / 8.74% |
No dataGOSS / S&P / 9.50% |
LoseGOSS / S&P -28.20% / -8.57% |
| 2023-Q10/2 |
LoseGOSS / S&P -41.94% / 7.50% |
No dataGOSS / S&P / 10.77% |
LoseGOSS / S&P -20.26% / -15.69% |
| 2022-Q41/2 |
LoseGOSS / S&P -81.89% / 7.56% |
No dataGOSS / S&P / 11.88% |
WinGOSS / S&P -13.10% / -17.99% |
| 2022-Q31/2 |
WinGOSS / S&P 43.13% / -4.88% |
No dataGOSS / S&P / 13.47% |
LoseGOSS / S&P -11.04% / -1.41% |
| 2022-Q21/2 |
WinGOSS / S&P -3.57% / -16.10% |
No dataGOSS / S&P / 13.71% |
LoseGOSS / S&P -6.44% / 11.04% |
| 2022-Q10/2 |
LoseGOSS / S&P -23.25% / -4.60% |
No dataGOSS / S&P / 15.97% |
LoseGOSS / S&P -10.12% / 42.23% |
| 2021-Q40/2 |
LoseGOSS / S&P -10.02% / 11.03% |
No dataGOSS / S&P / 15.00% |
LoseGOSS / S&P -11.83% / 96.40% |
| 2021-Q31/1 |
WinGOSS / S&P 54.80% / 0.58% |
No dataGOSS / S&P / 10.77% |
No dataGOSS / S&P / 69.42% |
| 2021-Q20/1 |
LoseGOSS / S&P -12.22% / 8.55% |
No dataGOSS / S&P / 6.58% |
No dataGOSS / S&P / 51.81% |
| 2021-Q10/1 |
LoseGOSS / S&P -4.34% / 6.17% |
No dataGOSS / S&P / -1.06% |
No dataGOSS / S&P / 7.39% |
| 2020-Q40/1 |
LoseGOSS / S&P -22.08% / 12.15% |
No dataGOSS / S&P / -3.72% |
No dataGOSS / S&P / -33.42% |
| 2020-Q30/1 |
LoseGOSS / S&P -4.54% / 8.93% |
No dataGOSS / S&P / -2.04% |
No dataGOSS / S&P / -27.10% |
| 2020-Q21/1 |
WinGOSS / S&P 28.08% / 20.54% |
No dataGOSS / S&P / -0.46% |
No dataGOSS / S&P / -27.11% |
| 2020-Q10/1 |
LoseGOSS / S&P -35.06% / -19.60% |
No dataGOSS / S&P / 3.47% |
No dataGOSS / S&P / -14.75% |
| 2019-Q40/1 |
LoseGOSS / S&P -6.91% / 9.07% |
No dataGOSS / S&P / 5.36% |
No dataGOSS / S&P / 2.99% |
| 2019-Q30/1 |
LoseGOSS / S&P -24.30% / 1.70% |
No dataGOSS / S&P / 5.02% |
No dataGOSS / S&P / 0.21% |
| 2019-Q20/1 |
LoseGOSS / S&P 2.35% / 4.30% |
No dataGOSS / S&P / 6.64% |
No dataGOSS / S&P / 8.65% |
| 2019-Q10/0 |
No dataGOSS / S&P / 13.65% |
No dataGOSS / S&P / 8.12% |
No dataGOSS / S&P / 14.29% |
| 2018-Q40/0 |
No dataGOSS / S&P / -13.52% |
No dataGOSS / S&P / 9.05% |
No dataGOSS / S&P / 18.23% |
| 2018-Q30/0 |
No dataGOSS / S&P / 7.71% |
No dataGOSS / S&P / 10.21% |
No dataGOSS / S&P / 19.06% |
| 2018-Q20/0 |
No dataGOSS / S&P / 3.43% |
No dataGOSS / S&P / 9.03% |
No dataGOSS / S&P / 14.46% |
| 2018-Q10/0 |
No dataGOSS / S&P / -0.76% |
No dataGOSS / S&P / 7.68% |
No dataGOSS / S&P / 12.46% |
| 2017-Q40/0 |
No dataGOSS / S&P / 6.64% |
No dataGOSS / S&P / 7.03% |
No dataGOSS / S&P / 13.82% |
| 2017-Q30/0 |
No dataGOSS / S&P / 4.48% |
No dataGOSS / S&P / 5.68% |
No dataGOSS / S&P / 17.57% |
| 2017-Q20/0 |
No dataGOSS / S&P / 3.09% |
No dataGOSS / S&P / 4.83% |
No dataGOSS / S&P / 17.74% |
| 2017-Q10/0 |
No dataGOSS / S&P / 6.07% |
No dataGOSS / S&P / 3.67% |
No dataGOSS / S&P / 13.32% |
| 2016-Q40/0 |
No dataGOSS / S&P / 3.82% |
No dataGOSS / S&P / 2.09% |
No dataGOSS / S&P / 7.05% |
| 2016-Q30/0 |
No dataGOSS / S&P / 3.85% |
No dataGOSS / S&P / 0.20% |
No dataGOSS / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | GOSS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -93.12% | 20.78% |
| Annualized return | -93.12% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | GOSS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.35% | 83.14% |
| Annualized return | -55.98% | 12.86% |
10Y · 2019-02-08 to 2026-08-27
| Metric | GOSS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.05% | 319.30% |
| Annualized return | -37.24% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |